Michael Linenberger photo
Professor, Division of Hematology, UW
Robert & Phyllis Henigson Endowed Chair
Program Director, Hematology/Oncology Fellowship
Medical Director, Apheresis and Cellular Therapy, SCCA
Professor, Clinical Research Division, Fred Hutch

Faculty Information


Dr. Linenberger is a Professor of Hematology and holds the Robert & Phyllis Henigson Endowed Chair at the University of Washington. He is the Medical Director of Apheresis and Cellular Therapy at the Seattle Cancer Care Alliance and Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center. He maintains a busy outpatient hematology practice at SCCA and he is the Program Director for the Hematology/Oncology fellowship at UW/Fred Hutch. Dr. Linenberger is also the Medical Director of the Cellular Processing Facility (a GMP production laboratory) of the Fred Hutchinson Cancer Research Center, which provides critical support and technical expertise for the procurement, characterization and manufacturing of cell-based products for the treatment of patients with malignant and non-malignant diseases. These include investigational protocols and a research specimen repository. Dr. Linenberger is also deeply involved in teaching, training and career development through his faculty and Program Director roles.

Education & Training: 
University of Kansas
Lawerence, KS
University of Kansas
Kansas City, KS
Department of Medicine, Rhode Island Hospital
Providence, RI
Department of Medicine, Division of Hematology, University of Washington
Seattle, WA
Robert and Phyllis Henigson Endowed Chair of Hematology
Invited to Co-Chair, ASH Hematology-Focused Fellowship Steering Subcommittee
Invited to Co-Chair ASFA Diversity & Inclusion Task Force
(206) 667-5021
Mailing Address: 

Fred Hutchinson Cancer Research Center (D5280)
1100 Fairview Avenue N.
Seattle, WA 98109

Research & Clinical Interests
Research Interests: 

Safe and effective management of patients and donors undergoing marrow harvest and peripheral blood stem cell mobilization and collection by apheresis

Clinical Interests: 

Hematologic malignancies, benign hematologic disorders, bleeding and thrombotic disorders, therapeutic apheresis and stem cell procurement


Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study. Switzer GE, Bruce JG, Kiefer DM, Kobusingye H, Abebe KZ, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, Riches M, Hayes-Lattin B, Linenberger M, Bolwell B, Rowley SD, Litzow MR, Pulsipher MA. Biol Blood Marrow Transplant. 2020 Dec;26(12):2365-2371. doi:10.1016/j.bbmt.2020.08.016. Epub 2020 Aug 21. PMID: 32829080

Updates on the diagnosis and management of the most common hereditary porphyrias: AIP and EPP. Linenberger M, Fertrin KY. Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):400-410. doi: 10.1182/hematology.2020000124. PMID: 33275677

Leukocytapheresis for AML hyperleukocytosis: Failing to make the grade. Connelly-Smith L, Linenberger ML.Transfusion. 2020 Oct;60(10):2161-2163. doi: 10.1111/trf.16091. PMID: 33615498

Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignancies. Tuazon SA, Li A, Gooley T, Eunson TW, Maloney DG, Turtle CJ, Linenberger ML, Connelly-Smith LS. Transfusion. 2019 May;59(5):1773-1780. doi: 10.1111/trf.15178. Epub 2019 Feb 6. PMID: 30729531

Choosing Wisely for apheresis. Connelly-Smith L, Tanhehco YC, Chhibber V, Delaney M, Eichbaum Q, Fernandez C, Joshi S, Schwartz J, Linenberger M. J Clin Apher. 2018 Oct;33(5):576-579. doi: 10.1002/jca.21643. PMID: 30325055

Transfusion practices for bone marrow harvests: a survey analysis from the AABB Bone Marrow Quality Improvement Initiative Working Group. Spitzer TR, Sugrue MW, Gonzalez C, O'Donnell P, Confer D, Fuchs E, Pulsipher MA, Schwartz J, Linenberger M. Bone Marrow Transplant. 2017 Aug;52(8):1199-1200. doi: 10.1038/bmt.2017.92. Epub 2017 May 22. PMID: 28530670